Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
- MACD is crossing MACD signal line at 1.3. MACD crossing signal line is bullish signal.
|Earning Growth (QoQ)||103%|
|Revenue Growth (QoQ)|
|Held by Institutions %||95%|
|1 Day Vol Adjusted Return||-1.2|
|1 Month Vol Adjusted Return||6.5|
|3 Month Vol Adjusted Return||6.6|
|6 Month Vol Adjusted Return||-8.3|
|20 Days SMA Price ZScore||1.0|
|50 Days SMA Price ZScore||1.7|
|12 -26 Days PPO||3.0|
|1 Month Average Short Volume Ratio||54.1|
|1 Day Volume Change ZScore||-1.2|
|1 Month Daily Vol||2.0|
In this article, we will discuss 50 biggest dividend kings and dividend aristocrats. You can skip our detailed analysis of dividend stocks and their returns in the past, and go directly to read Dividend Kings and Aristocrats List: 10 Biggest Stocks. Dividend Aristocrats and Dividend Kings are the companies that have raised their dividend payouts for […]
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 12, 2023, at 9:00 am PST.
Conestoga Capital Advisors, an asset management company, released its “Conestoga Mid Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the Mid Cap composite returned -4.84% net of fees compared to a -0.65% return for the Russell Mid Cap Growth Index. Negative stock selection and allocation effects […]
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share. The dividend will be paid on February 1, 2023, to shareholders of record as of January 25, 2023.
West Pharmaceutical Services (NYSE:WST) has had a rough three months with its share price down 25%. But if you pay...
Next year isn’t very far away. In less than two months, we’ll be ringing in the New Year and making resolutions. Many of those resolutions will revolve around making better investment decisions. And looking for dividend stocks to buy is a great decision because many of these stocks are set to surge higher in 2023. Dividends are cash paid to the owners of stock. Companies that pay dividends tend to be mature. That means their days of rapid growth are often behind them. To some, that makes them le
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the Jefferies London Healthcare Conference in London, UK on Tuesday, November 15 at 3:50 PM GMT (11:50 AM ET).
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPhI Worldwide in Frankfurt, Germany to showcase its leadership and expertise on industry challenges and trends in packaging and containment.
The last three months have been tough on West Pharmaceutical Services, Inc. ( NYSE:WST ) shareholders, who have seen...